• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

MindMed Posts Positive Phase II Results for LSD-Based Treatment for Anxiety

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Dec 17, 2023 at 10:32: PM
via New York-based biotech MindMed on Thursday reported topline results from a Phase IIb trial of its LSD-based candidate MM-120 (lysergide d-tartrate), which met the study’s primary endpoint in patients with generalized anxiety disorder.

article source
 




Top Bottom
Back
Quote